Zevra Therapeutics Inc. (ZVRA) — Long-term Investment Intensity
Zevra Therapeutics Inc. (ZVRA) has a Long-term Investment Intensity of 11.4% as of September 2025. Long-term investments of $30.86 Million represent 11.4% of total assets of $270.12 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Zevra Therapeutics Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Zevra Therapeutics Inc. Long-term Investment Intensity (2021–2024)
This chart shows how Zevra Therapeutics Inc.'s Long-term Investment Intensity has evolved across 3 annual periods from 2021 to 2024. As of September 2025, the intensity stands at 11.4%, reflecting long-term investments of $30.86 Million against total assets of $270.12 Million USD. Explore ZVRA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Zevra Therapeutics Inc. (2021–2024)
The table below presents the year-by-year Long-term Investment Intensity for Zevra Therapeutics Inc. from 2021 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Zevra Therapeutics Inc. stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 3.4% | $6.01 Million | $178.13 Million | ▼ -14.0 pp |
| 2022 | 17.3% | $20.00 Million | $115.34 Million | ▲ +5.7 pp |
| 2021 | 11.6% | $15.42 Million | $132.94 Million | — |